BIO
Beyond's analysis on BIO
Recent news mentioning BIO
- — Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- — INVESTOR DEADLINE: PROCEPT BioRobotics Corporation (PRCT) Investors with Substantial Losses Have Opportunity to Lead the PROCEPT Class Action Lawsuit Before September 22, 2026
- — Ministry of Food and Drug Safety of Korea, Successfully Concludes 'GBC 2026,' Marking a Great Leap in Bio
- — Nature Biotechnology | Insilico's AI-Driven IPF Candidate Rentosertib Shows Potential for Biological Age Reversal, as Assessed by Six Proteomic Aging Clocks
- — CelluPro obtient la certification EXCiPACT™ pour la fabrication de milieux de culture cellulaire conformes aux bonnes pratiques de fabrication (Good Manufacturing Practices (GMP)), renforçant ainsi ses capacités mondiales d'approvisionnement en produits issus de la biofabrication
- — CelluPro Receives EXCiPACT™ Certification for GMP-grade Cell Culture Media Manufacturing, Strengthening Global Biomanufacturing Supply Capabilities
- — CelluPro erhält EXCiPACT™-Zertifizierung für die Herstellung von Zellkulturmedien in GMP-Qualität und stärkt damit seine globalen Lieferkapazitäten im Bereich der biopharmazeutischen Produktion
- — CelluPro Receives EXCiPACT™ Certification for GMP-grade Cell Culture Media Manufacturing, Strengthening Global Biomanufacturing Supply Capabilities
- — Europe cannot afford to lose the race for biomedical innovation
- — Harbour BioMed Successfully Included in the Stock Connect, Reinforcing Capital Market Recognition
- — Jim Cramer sends strong 5-word message on surging biotech stock
- — Cernobbio, netta bocciatura alla politica estera di Trump. Meno giudizi positivi al governo Meloni
Appears alongside
Browse the full archive →